Free Trial

Integral Ad Science (NASDAQ:IAS) Price Target Lowered to $13.00 at Raymond James

Integral Ad Science logo with Business Services background

Integral Ad Science (NASDAQ:IAS - Free Report) had its target price cut by Raymond James from $16.00 to $13.00 in a research note published on Friday morning, Benzinga reports. They currently have an outperform rating on the stock.

A number of other analysts also recently weighed in on IAS. Bank of America started coverage on shares of Integral Ad Science in a report on Thursday, January 11th. They set a buy rating and a $19.00 price target for the company. Morgan Stanley reiterated an equal weight rating and set a $12.00 price objective (down from $18.00) on shares of Integral Ad Science in a research report on Tuesday, April 16th. Truist Financial lowered their price objective on shares of Integral Ad Science from $26.00 to $17.00 and set a buy rating for the company in a research report on Wednesday, February 28th. Benchmark reiterated a hold rating on shares of Integral Ad Science in a research report on Tuesday. Finally, Oppenheimer lowered their price objective on shares of Integral Ad Science from $25.00 to $20.00 and set an outperform rating for the company in a research report on Wednesday, February 28th. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of Moderate Buy and a consensus price target of $16.77.


View Our Latest Analysis on IAS

Integral Ad Science Price Performance

Shares of Integral Ad Science stock traded up $1.15 on Friday, reaching $9.53. 5,865,299 shares of the stock were exchanged, compared to its average volume of 1,864,019. The firm's 50 day moving average is $9.63 and its 200-day moving average is $12.78. Integral Ad Science has a one year low of $7.98 and a one year high of $20.88. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.21 and a current ratio of 3.21. The firm has a market cap of $1.52 billion, a PE ratio of 238.31, a P/E/G ratio of 1.72 and a beta of 1.58.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The company had revenue of $114.50 million during the quarter, compared to the consensus estimate of $112.12 million. During the same quarter in the prior year, the firm posted $0.02 EPS. The firm's quarterly revenue was up 7.9% on a year-over-year basis. As a group, analysts anticipate that Integral Ad Science will post 0.16 EPS for the current fiscal year.

Insider Transactions at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 30,407 shares of the stock in a transaction on Monday, April 8th. The shares were sold at an average price of $10.05, for a total transaction of $305,590.35. Following the transaction, the chief executive officer now directly owns 188,678 shares of the company's stock, valued at $1,896,213.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Integral Ad Science news, CAO Alexis Gil II sold 3,177 shares of the firm's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $10.24, for a total value of $32,532.48. Following the transaction, the chief accounting officer now directly owns 120,195 shares of the company's stock, valued at $1,230,796.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Lisa Utzschneider sold 30,407 shares of the firm's stock in a transaction on Monday, April 8th. The shares were sold at an average price of $10.05, for a total transaction of $305,590.35. Following the completion of the transaction, the chief executive officer now directly owns 188,678 shares in the company, valued at $1,896,213.90. The disclosure for this sale can be found here. Insiders sold a total of 75,126 shares of company stock worth $749,707 over the last three months. 2.00% of the stock is owned by company insiders.

Institutional Trading of Integral Ad Science

Institutional investors and hedge funds have recently made changes to their positions in the company. Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Integral Ad Science in the third quarter valued at about $58,000. DekaBank Deutsche Girozentrale purchased a new stake in Integral Ad Science during the third quarter worth about $62,000. Amalgamated Bank increased its holdings in Integral Ad Science by 19.9% during the third quarter. Amalgamated Bank now owns 6,951 shares of the company's stock worth $83,000 after buying an additional 1,156 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new stake in Integral Ad Science during the third quarter worth about $140,000. Finally, L2 Asset Management LLC purchased a new stake in Integral Ad Science during the third quarter worth about $142,000. Hedge funds and other institutional investors own 95.78% of the company's stock.

Integral Ad Science Company Profile

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Featured Stories

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

→ Write this ticker symbol down… (From StocksToTrade) (Ad)

Should you invest $1,000 in Integral Ad Science right now?

Before you consider Integral Ad Science, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.

While Integral Ad Science currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Featured Articles and Offers

Roblox Reality Check: Why the Metaverse Isn't Saving the Stock!

Roblox Reality Check: Why the Metaverse Isn't Saving the Stock!

Roblox's good quarter is overshadowed by high expectations and weak guidance, resulting in a 30% stock implosion.

Search Headlines: